MX370448B - Derivados de 6- [4- (1h-imidazol-2-il) piperidin-1-il] pirimidin-4-amina como moduladores de la actividad de cinasa. - Google Patents

Derivados de 6- [4- (1h-imidazol-2-il) piperidin-1-il] pirimidin-4-amina como moduladores de la actividad de cinasa.

Info

Publication number
MX370448B
MX370448B MX2015011660A MX2015011660A MX370448B MX 370448 B MX370448 B MX 370448B MX 2015011660 A MX2015011660 A MX 2015011660A MX 2015011660 A MX2015011660 A MX 2015011660A MX 370448 B MX370448 B MX 370448B
Authority
MX
Mexico
Prior art keywords
imidazol
pyrimidin
piperidin
modulators
kinase activity
Prior art date
Application number
MX2015011660A
Other languages
English (en)
Other versions
MX2015011660A (es
Inventor
Goutopoulos Andreas
R Huck Bayard
Chen Xiaoling
Xiao Yufang
Lan Ruoxi
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of MX2015011660A publication Critical patent/MX2015011660A/es
Publication of MX370448B publication Critical patent/MX370448B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Abstract

La invención proporciona nuevas aminas heterocíclicas de acuerdo con la fórmula (I), su fabricación y uso para el tratamiento de enfermedades hiperproliferativas, tales como cáncer.
MX2015011660A 2013-03-11 2014-03-10 Derivados de 6- [4- (1h-imidazol-2-il) piperidin-1-il] pirimidin-4-amina como moduladores de la actividad de cinasa. MX370448B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361776440P 2013-03-11 2013-03-11
PCT/US2014/022479 WO2014143612A1 (en) 2013-03-11 2014-03-10 6-[4-(1 h-imidazol-2-yl)piperidin-1 -yl]pyrimidin-4-amine derivatives as modulators of kinase activity

Publications (2)

Publication Number Publication Date
MX2015011660A MX2015011660A (es) 2015-12-16
MX370448B true MX370448B (es) 2019-12-13

Family

ID=50440836

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015011660A MX370448B (es) 2013-03-11 2014-03-10 Derivados de 6- [4- (1h-imidazol-2-il) piperidin-1-il] pirimidin-4-amina como moduladores de la actividad de cinasa.

Country Status (17)

Country Link
US (2) US9458134B2 (es)
EP (1) EP2970201B1 (es)
JP (1) JP6483656B2 (es)
KR (1) KR20150124957A (es)
CN (1) CN105209454A (es)
AR (1) AR095202A1 (es)
AU (1) AU2014228385B2 (es)
BR (1) BR112015021324A2 (es)
CA (1) CA2902755C (es)
ES (1) ES2746756T3 (es)
HK (1) HK1218756A1 (es)
IL (1) IL240875B (es)
MX (1) MX370448B (es)
RU (1) RU2674261C2 (es)
SG (2) SG11201505999VA (es)
WO (1) WO2014143612A1 (es)
ZA (1) ZA201505749B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2970201B1 (en) * 2013-03-11 2019-06-19 Merck Patent GmbH 6-[4-(1h-imidazol-2-yl)piperidin-1-yl]pyrimidin-4-amine derivatives as modulators of kinase activity
SG11201605121VA (en) * 2014-02-11 2016-07-28 Merck Patent Gmbh Pyrimidine imidazole amines as modulators of kinase activity
BR112016020135A8 (pt) * 2014-04-03 2021-07-06 Merck Patent Gmbh mistura de composto, seus usos, composição farmacêutica, e conjunto (kit)
MA45048A (fr) * 2016-05-20 2019-03-27 Taiho Pharmaceutical Co Ltd Nouveau dérivé de 5h-pyrrolo[2,3-d]pyrimidin-6(7h)-one
CN110922354B (zh) * 2019-12-12 2023-05-02 丽水绿氟科技有限公司 一种1-r-3-氟哌啶-4-羧酸的化学拆分制备方法及其产物
US11866421B2 (en) 2021-05-31 2024-01-09 Epigen Biosciences, Inc. Pyrimidine and pyridine amine compounds and usage thereof in disease treatment

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200306819A (en) 2002-01-25 2003-12-01 Vertex Pharma Indazole compounds useful as protein kinase inhibitors
ES2399047T3 (es) * 2002-09-20 2013-03-25 Merck Serono Sa Derivados de piperazina y procedimiento de uso
EP1615906A1 (en) 2003-04-03 2006-01-18 Vertex Pharmaceuticals Incorporated Compositions useful as inhibitors of protein kinases
JP2007507531A (ja) 2003-09-30 2007-03-29 アイアールエム・リミテッド・ライアビリティ・カンパニー タンパク質キナーゼ阻害剤としての化合物および組成物
JP4800216B2 (ja) 2003-10-24 2011-10-26 エグゼリクシス， インコーポレイテッド ｐ７０Ｓ６キナーゼモジュレーターおよび使用方法
AU2004295061B2 (en) 2003-11-21 2008-11-20 Novartis Ag 1H-imidazoquinoline derivatives as protein kinase inhibitors
DE602004024115D1 (de) 2003-12-09 2009-12-24 Us Gov Health & Human Serv Verfahren zur unterdrückung einer immunantwort oder zur behandlung von proliferativen erkrankungen
GB0403606D0 (en) * 2004-02-18 2004-03-24 Novartis Ag Organic compounds
WO2005117909A2 (en) 2004-04-23 2005-12-15 Exelixis, Inc. Kinase modulators and methods of use
US7994172B2 (en) 2004-12-28 2011-08-09 Exelixis, Inc. [1H-pyrazolo[3, 4-D]pyrimidin-4-yl]-piperidine or -piperazine compounds as serine-theoronine kinase modulators (P70s6k, Atk1 and Atk2) for the treatment of immunological, inflammatory and proliferative diseases
GB0501999D0 (en) 2005-02-01 2005-03-09 Sentinel Oncology Ltd Pharmaceutical compounds
WO2006136821A1 (en) 2005-06-22 2006-12-28 Astex Therapeutics Limited Pharmaceutical compounds
AR064416A1 (es) * 2006-12-21 2009-04-01 Cancer Rec Tech Ltd Derivados de purina, piridina y pirimidina condensadas con heterociclos, moduladores de pka y/o pkb, composiciones farmaceuticas que los contienen, y usos para el tratamiento de enfermedades hiperproliferativas.
UA99284C2 (ru) * 2007-05-11 2012-08-10 Елі Ліллі Енд Компані ИНГИБИТОРЫ р70 S6-КИНАЗЫ
AR074072A1 (es) * 2008-11-11 2010-12-22 Lilly Co Eli Compuesto de imidazol -piperidin -pirrol-pirimidin-6-ona, composicion farmaceutica que lo comprende y su uso para preparar un medicamento util para tratar el glioblastoma multiforme
CN102209539B (zh) * 2008-11-11 2013-06-12 伊莱利利公司 P70 s6激酶抑制剂和mtor抑制剂的组合治疗剂
MX2011005002A (es) * 2008-11-11 2011-05-25 Lilly Co Eli Inhibidor de p70 s6 quinasa y terapia de combinacion de inhibidor del receptor de egfr.
DK2396307T3 (en) 2009-02-11 2015-01-12 Merck Patent Gmbh NOVEL AMINO-azaheterocyclic carboxamides
WO2011050016A1 (en) * 2009-10-23 2011-04-28 Eli Lilly And Company Akt inhibitors
UA110113C2 (xx) 2010-07-29 2015-11-25 Біциклічні азагетероциклічні карбоксаміди
WO2012016001A1 (en) 2010-07-29 2012-02-02 Merck Patent Gmbh Cyclic amine azaheterocyclic carboxamides
MX355325B (es) 2010-11-24 2018-04-16 Merck Patent Gmbh Quinazolincarboxamida azetidinas.
JP2014517016A (ja) * 2011-06-10 2014-07-17 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング Ｂｔｋ阻害活性を有するピリミジンおよびピリミジン化合物の組成物と製造方法
EP2734517B1 (en) * 2011-07-18 2017-08-30 Merck Patent GmbH Benzamides
LT2755958T (lt) * 2011-09-12 2017-11-10 Merck Patent Gmbh Aminopirimidino dariniai, skirti naudoti kaip kinazės aktyvumo moduliatoriai
SI2755965T1 (sl) * 2011-09-12 2017-12-29 Merck Patent Gmbh Novi imidazolni amidi kot modulatorji kinazne aktivnosti
MX353062B (es) * 2011-12-22 2017-12-19 Merck Patent Gmbh Nuevas carboxamidas heterociclicas como moduladores de la activadad de cinasas.
US10227357B2 (en) * 2012-09-06 2019-03-12 Plexxikon Inc. Compounds and methods for kinase modulation, and indications therefor
JP6280130B2 (ja) * 2012-11-16 2018-02-14 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングＭｅｒｃｋ Ｐａｔｅｎｔ Ｇｅｓｅｌｌｓｃｈａｆｔ ｍｉｔ ｂｅｓｃｈｒａｅｎｋｔｅｒ Ｈａｆｔｕｎｇ キナーゼ活性のモジュレーターとしての新規イミダゾール−ピペリジニル誘導体
EP2970201B1 (en) * 2013-03-11 2019-06-19 Merck Patent GmbH 6-[4-(1h-imidazol-2-yl)piperidin-1-yl]pyrimidin-4-amine derivatives as modulators of kinase activity
SG11201605121VA (en) * 2014-02-11 2016-07-28 Merck Patent Gmbh Pyrimidine imidazole amines as modulators of kinase activity
US9771369B2 (en) * 2014-03-04 2017-09-26 Plexxikon Inc. Compounds and methods for kinase modulation, and indications therefor

Also Published As

Publication number Publication date
AR095202A1 (es) 2015-09-30
JP6483656B2 (ja) 2019-03-13
US9458134B2 (en) 2016-10-04
KR20150124957A (ko) 2015-11-06
US20160016936A1 (en) 2016-01-21
IL240875A0 (en) 2015-10-29
AU2014228385B2 (en) 2018-08-09
BR112015021324A2 (pt) 2017-07-18
MX2015011660A (es) 2015-12-16
EP2970201A1 (en) 2016-01-20
AU2014228385A1 (en) 2015-08-20
HK1218756A1 (zh) 2017-03-10
ES2746756T3 (es) 2020-03-06
SG11201505999VA (en) 2015-08-28
ZA201505749B (en) 2017-01-25
US20160361316A1 (en) 2016-12-15
CN105209454A (zh) 2015-12-30
RU2015143160A3 (es) 2018-03-01
JP2016512509A (ja) 2016-04-28
SG10201900954SA (en) 2019-02-27
CA2902755A1 (en) 2014-09-18
RU2015143160A (ru) 2017-04-18
RU2674261C2 (ru) 2018-12-06
US9867826B2 (en) 2018-01-16
WO2014143612A1 (en) 2014-09-18
CA2902755C (en) 2021-02-16
IL240875B (en) 2020-08-31
EP2970201B1 (en) 2019-06-19

Similar Documents

Publication Publication Date Title
MX2022002581A (es) Compuestos de benzimidazol como inhibidores de c-kit.
PH12017502090A1 (en) Heterocyclic amides as kinase inhibitors
PH12016501898A1 (en) Quinoxaline derivatives useful as fgfr kinase modulators
MX2014002836A (es) Derivados de aminopirimidina para usarse como moduladores de la actividad de cinasa.
MX2015000129A (es) Derivados de pirimidin pirazolilo.
PH12015500963A1 (en) Tricyclic fused thiophene derivatives as jak inhibitors
TN2014000138A1 (en) Substituted benzylindazoles for use as bub1 kinase inhibitors in the treatment of hyperproliferative diseases.
MX2016010571A (es) Pirazolil-ureas como inhibidores de quinasas.
MX2015013481A (es) Compuestos heterociclicos fusionados como inhibidores de proteina quinasa.
MX2016004340A (es) Compuestos heterociclicos y usos de los mismos.
MX368066B (es) Derivados de quinazolin-4-ona sustituida.
MX2015014234A (es) Derivados 2-aminopirido-[4,3-d]pirimidin-5-ona y su uso como inhibidores de wee-1.
UA113470C2 (xx) Піримідинові та піридинові сполуки та їх застосування
MX2015011660A (es) Derivados der 6-[4-(1h-imidazol-2-il)piperidin-1-il]pirimidin-4-am ina como moduladores de la actividad de cinasa.
TN2015000120A1 (en) Oxazolidin-2-one-pyrimidine derivatives
MX2014002832A (es) Nuevas imidazol-aminas como moduladores de la actividad de cinasas.
GEP20166489B (en) 1h-indazole-3-carboxamide compounds as glycogen synthase kinase 3 beta inhibitors
MX2016007810A (es) Derivados de n1-(3,3,3-trifluoro-2-hidroxo-2-metilpropionil)-piper idina como inhibidores de piruvato deshidrogenasa cinasa.
MX353062B (es) Nuevas carboxamidas heterociclicas como moduladores de la activadad de cinasas.
PH12015502746A1 (en) Prodrug derivatives of substituted triazolopyridines
MX2016010268A (es) Pirimidinimidazolaminas como modulares de actividad de cinasa.
DK3057580T3 (da) Farmaceutiske administrationsformer indeholdende natrium-1-[6-(morpholin-4-yl)pyrimidin-4-yl]-4-(1h-1,2,3-triazol-1-yl)-1h-pyrazol-5-olat
MX2015009678A (es) Compuestos de pirimidina condensada sustituida con amino en la posicion 4 como inhibidores de fosfodiesterasa 4 (pde4).
LV14779A (lv) 4-Amino-2-(1,2,3-triazol-1-il)-hinazolīna atvasinājumi un to sintēzes paņēmiens

Legal Events

Date Code Title Description
FG Grant or registration